Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis

Cell Communication and Signaling

Volumn 8, Issue , 2010, Pages

  Wolf, Susanne A ^a,b   Bick Sander, Anika ^a   Fabel, Klaus ^d   Leal Galicia, Perla ^d   Tauber, Svantje ^b   Ramirez Rodriguez, Gerardo ^a,c   Müller, Anke ^a   Melnik, Andre ^b   Waltinger, Tim P ^b   Ullrich, Oliver ^b   Kempermann, Gerd ^a,d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953565298     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-8-12     Document Type: Article

References (76)

1. Discovery and characterization of endogenous cannabinoids. BR Martin, R Mechoulam, RK Razdan, Life Sci 1999 65 573 595 10.1016/S0024-3205(99)00281-7 10462059 (Pubitemid 29362764)
2. Endocannabinoids and traumatic brain injury. R Mechoulam, E Shohami, Mol Neurobiol 2007 36 68 74 10.1007/s12035-007-8008-6 17952651 (Pubitemid 351360359)
3. Endocannabinoids and neuroprotection. R Mechoulam, M Spatz, E Shohami, Sci STKE 2002 2002 e5 10.1126/stke.2002.129.re5 11972360
4. Cannabinoids in health and disease. NM Kogan, R Mechoulam, Dialogues Clin Neurosci 2007 9 413 430 18286801 (Pubitemid 351187565)
5. Health aspects of cannabis: revisited. LE Hollister, Int J Neuropsychopharmacol 1998 1 71 80 10.1017/S1461145798001060 11281947 (Pubitemid 128538367)
6. Cannabinoids: between neuroprotection and neurotoxicity. Y Sarne, R Mechoulam, Curr Drug Targets CNS Neurol Disord 2005 4 677 684 10.2174/156800705774933005 16375685 (Pubitemid 41782629)
7. Chronic treatment with Delta(9)-tetrahydrocannabinol impairs spatial memory and reduces zif268 expression in the mouse forebrain. AA Boucher, L Vivier, M Metna-Laurent, L Brayda-Bruno, N Mons, JC Arnold, J Micheau, Behav Pharmacol 2009 20 45 55 10.1097/FBP.0b013e3283242f6a 19179850
8. Functional significance of adult neurogenesis. G Kempermann, L Wiskott, FH Gage, Curr Opin Neurobiol 2004 14 186 191 10.1016/j.conb.2004.03.001 15082323 (Pubitemid 38479935)
9. Depressed new neurons - adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. G Kempermann, G Kronenberg, Biol Psychiatry 2003 54 499 503 10.1016/S0006-3223(03)00319-6 12946878 (Pubitemid 37289436)
10. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. A Reif, S Fritzen, M Finger, A Strobel, M Lauer, A Schmitt, KP Lesch, Mol Psychiatry 2006 11 514 522 10.1038/sj.mp.4001791 16415915
11. Autoradiographic study of degenerative and regenerative proliferation of neuroglia cells with tritiated thymidine. J Altman, Exp Neurol 1962 5 302 318 10.1016/0014-4886(62)90040-7 13860749
12. Principles of neurogenesis, neuronal migration, and neural circuit formation. SA Bayer, J Altman, The Rat Nervous System The Rat Nervous System: The Rat Nervous System, Paxinos G, 1995 1079 1098
13. Endocannabinoids and the brain immune system: new neurones at the horizon? SA Wolf, O Ullrich, J Neuroendocrinol 2008 20 Suppl 1 15 19 10.1111/j.1365-2826.2008.01672.x 18426494 (Pubitemid 351552671)
14. Emerging strategies for exploiting cannabinoid receptor agonists as medicines. RG Pertwee, Br J Pharmacol 2009 156 397 411 10.1111/j.1476-5381.2008. 00048.x 19226257
15. Cannabidiol - recent advances. R Mechoulam, M Peters, E Murillo-Rodriguez, LO Hanus, Chem Biodivers 2007 4 1678 1692 10.1002/cbdv.200790147 17712814 (Pubitemid 47377200)
16. Cannabidiol for the treatment of psychosis in Parkinson's disease. AW Zuardi, JA Crippa, JE Hallak, JP Pinto, MH Chagas, GG Rodrigues, SM Dursun, V Tumas, J Psychopharmacol 2009 23 979 983 10.1177/0269881108096519 18801821
17. Cannabidiol monotherapy for treatment-resistant schizophrenia. AW Zuardi, JE Hallak, SM Dursun, SL Morais, RF Sanches, RE Musty, JA Crippa, J Psychopharmacol 2006 20 683 686 10.1177/0269881106060967 16401651 (Pubitemid 44321696)
18. Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants. AJ Hampson, M Grimaldi, J Axelrod, D Wink, Proc Natl Acad Sci USA 1998 95 8268 8273 10.1073/pnas.95.14.8268 9653176 (Pubitemid 28326102)
19. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. A Thomas, GL Baillie, AM Phillips, RK Razdan, RA Ross, RG Pertwee, Br J Pharmacol 2007 150 613 623 10.1038/sj.bjp.0707133 17245363 (Pubitemid 46355558)
20. The emerging functions of endocannabinoid signaling during CNS development. T Harkany, M Guzman, I Galve-Roperh, P Berghuis, LA Devi, K Mackie, Trends Pharmacol Sci 2007 28 83 92 10.1016/j.tips.2006.12.004 17222464 (Pubitemid 46161836)
21. The endocannabinoid system drives neural progenitor proliferation. T Aguado, K Monory, J Palazuelos, N Stella, B Cravatt, B Lutz, G Marsicano, Z Kokaia, M Guzman, I Galve-Roperh, Faseb J 2005 19 1704 1706 16037095 (Pubitemid 41429536)
22. A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. MB Goncalves, P Suetterlin, P Yip, F Molina-Holgado, DJ Walker, MJ Oudin, MP Zentar, S Pollard, RJ Yanez-Munoz, G Williams, et al. Mol Cell Neurosci 2008 38 526 536 10.1016/j.mcn.2008.05.001 18562209
23. The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. T Aguado, J Palazuelos, K Monory, N Stella, B Cravatt, B Lutz, G Marsicano, Z Kokaia, M Guzman, I Galve-Roperh, J Neurosci 2006 26 1551 1561 10.1523/JNEUROSCI.3101-05.2006 16452678 (Pubitemid 43237025)
24. Acute activation of CB1 cannabinoid receptors transiently decreases PSA-NCAM expression in the dentate gyrus of the rat hippocampus. M Mackowiak, A Chocyk, K Markowicz-Kula, K Wedzony, Brain Res 2007 1148 43 52 10.1016/j.brainres.2007.02.014 17355876 (Pubitemid 46602160)
25. Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects. W Jiang, Y Zhang, L Xiao, J Van Cleemput, SP Ji, G Bai, X Zhang, J Clin Invest 2005 115 3104 3116 10.1172/JCI25509 16224541 (Pubitemid 41567575)
26. The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis. T Aguado, E Romero, K Monory, J Palazuelos, M Sendtner, G Marsicano, B Lutz, M Guzman, I Galve-Roperh, J Biol Chem 2007 282 23892 23898 10.1074/jbc.M700678200 17556369 (Pubitemid 47328042)
27. The endocannabinoid anandamide inhibits neuronal progenitor cell differentiation through attenuation of the Rap1/B-Raf/ERK pathway. D Rueda, B Navarro, A Martinez-Serrano, M Guzman, I Galve-Roperh, J Biol Chem 2002 277 46645 46650 10.1074/jbc.M206590200 12237305 (Pubitemid 35417665)
28. Seizure-associated, aberrant neurogenesis in adult rats characterized with retrovirus-mediated cell labeling. S Jessberger, C Zhao, N Toni, GD Clemenson, Y Li, FH Gage, J Neurosci 2007 27 9400 9407 10.1523/JNEUROSCI.2002- 07.2007 17728453 (Pubitemid 47358204)
29. Seizures induce proliferation and dispersion of doublecortin-positive hippocampal progenitor cells. S Jessberger, B Romer, H Babu, G Kempermann, Exp Neurol 2005 196 342 351 10.1016/j.expneurol.2005.08.010 16168988 (Pubitemid 41607823)
30. Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice. K Jin, L Xie, SH Kim, S Parmentier-Batteur, Y Sun, XO Mao, J Childs, DA Greenberg, Mol Pharmacol 2004 66 204 208 10.1124/mol.66.2.204 15266010 (Pubitemid 38989476)
31. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. LJ Kochman, AA dos Santos, CA Fornal, BL Jacobs, Brain Res 2006 1113 86 93 10.1016/j.brainres. 2006.07.080 16930565 (Pubitemid 44419390)
32. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. MA Huestis, DA Gorelick, SJ Heishman, KL Preston, RA Nelson, ET Moolchan, RA Frank, Arch Gen Psychiatry 2001 58 322 328 10.1001/archpsyc.58.4.322 11296091 (Pubitemid 32299527)
33. Regulation of adult hippocampal neurogenesis-implications for novel theories of major depression. G Kempermann, Bipolar Disord 2002 4 17 33 10.1034/j.1399-5618.2002.40101.x 12047492 (Pubitemid 34567273)
34. Adult-generated hippocampal neurons allow the flexible use of spatially precise learning strategies. A Garthe, J Behr, G Kempermann, PLoS ONE 2009 4 5464 10.1371/journal.pone.0005464 19421325
35. CD4-positive T lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. SA Wolf, B Steiner, A Akpinarli, T Kammertoens, C Nassenstein, A Braun, T Blankenstein, G Kempermann, J Immunol 2009 182 3979 3984 10.4049/jimmunol.0801218 19299695
36. Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes. V Filippov, G Kronenberg, T Pivneva, K Reuter, B Steiner, LP Wang, M Yamaguchi, H Kettenmann, G Kempermann, Mol Cell Neurosci 2003 23 373 382 10.1016/S1044-7431(03)00060-5 12837622 (Pubitemid 36802008)
37. Transient calretinin expression defines early postmitotic step of neuronal differentiation in adult hippocampal neurogenesis of mice. MD Brandt, S Jessberger, B Steiner, G Kronenberg, K Reuter, A Bick-Sander, W von der Behrens, G Kempermann, Mol Cell Neurosci 2003 24 603 613 10.1016/S1044-7431(03) 00207-0 14664811 (Pubitemid 37506005)
38. Milestones of neuronal development in the adult hippocampus. G Kempermann, S Jessberger, B Steiner, G Kronenberg, Trends Neurosci 2004 27 447 452 10.1016/j.tins.2004.05.013 15271491 (Pubitemid 38951037)
39. Selective targeting of adenoviral vectors to neural precursor cells in the hippocampus of adult mice: new prospects for in situ gene therapy. A Schmidt, SJ Haas, S Hildebrandt, J Scheibe, B Eckhoff, T Racek, G Kempermann, A Wree, BM Putzer, Stem Cells 2007 25 2910 2918 10.1634/stemcells.2007-0238 17641242 (Pubitemid 350127876)
40. Subpopulations of proliferating cells of the adult hippocampus respond differently to physiologic neurogenic stimuli. G Kronenberg, K Reuter, B Steiner, MD Brandt, S Jessberger, M Yamaguchi, G Kempermann, J Comp Neurol 2003 467 455 463 10.1002/cne.10945 14624480 (Pubitemid 37467122)
41. Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. CJ Heyser, RE Hampson, SA Deadwyler, J Pharmacol Exp Ther 1993 264 294 307 8380864 (Pubitemid 23309216)
42. Is there a link between adult neurogenesis and learning? B Leuner, E Gould, TJ Shors, Hippocampus 2006 16 216 224 10.1002/hipo.20153 16421862
43. Hippocampal neurogenesis is not required for behavioral effects of environmental enrichment. D Meshi, MR Drew, M Saxe, MS Ansorge, D David, L Santarelli, C Malapani, H Moore, R Hen, Nat Neurosci 2006 9 729 731 10.1038/nn1696 16648847
44. A role for adult neurogenesis in spatial long-term memory. JS Snyder, NS Hong, RJ McDonald, JM Wojtowicz, Neuroscience 2005 130 843 852 10.1016/j.neuroscience.2004.10.009 15652983 (Pubitemid 40094618)
45. Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain. Y Marchalant, HM Brothers, GL Wenk, Mol Psychiatry 2009 14 1068 1069 10.1038/mp.2009.62 19920834
46. Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies. RG Steen, C Mull, R McClure, RM Hamer, JA Lieberman, Br J Psychiatry 2006 188 510 518 10.1192/bjp.188.6.510 16738340 (Pubitemid 43844097)
47. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. AW Zuardi, JA Crippa, JE Hallak, FA Moreira, FS Guimaraes, Braz J Med Biol Res 2006 39 421 429 10.1590/S0100-879X2006000400001 16612464
48. Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. CJ Morgan, HV Curran, Br J Psychiatry 2008 192 306 307 10.1192/bjp.bp.107.046649 18378995 (Pubitemid 351692406)
49. Cannabinoids modulate hippocampal memory and plasticity. H Abush, I Akirav, Hippocampus 2009 19830813
50. Cerebellar CB(1) receptor mediation of Delta(9)-THC-induced motor incoordination and its potentiation by ethanol and modulation by the cerebellar adenosinergic A(1) receptor in the mouse. MS Dar, Brain Res 2000 864 186 194 10.1016/S0006-8993(00)02103-X 10802025 (Pubitemid 30235100)
51. Cannabinoid-induced motor incoordination through the cerebellar CB(1) receptor in mice. KP DeSanty, MS Dar, Pharmacol Biochem Behav 2001 69 251 259 10.1016/S0091-3057(01)00539-1 11420093 (Pubitemid 32566270)
52. Motor effects of delta 9 THC in cerebellar Lurcher mutant mice. T Lorivel, P Hilber, Behav Brain Res 2007 181 248 253 10.1016/j.bbr.2007.04.011 17531329 (Pubitemid 46898661)
53. Cannabinoids in medicine: A review of their therapeutic potential. M Ben Amar, J Ethnopharmacol 2006 105 1 25 10.1016/j.jep.2006.02.001 16540272
54. Medical marijuana: emerging applications for the management of neurologic disorders. GT Carter, V Ugalde, Phys Med Rehabil Clin N Am 2004 15 943 954 ix 15458761 (Pubitemid 39349072)
55. Sativex: clinical efficacy and tolerability in the treatment of symptoms of multiple sclerosis and neuropathic pain. MP Barnes, Expert Opin Pharmacother 2006 7 607 615 10.1517/14656566.7.5.607 16553576
56. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice. R Capasso, F Borrelli, G Aviello, B Romano, C Scalisi, F Capasso, AA Izzo, Br J Pharmacol 2008 154 1001 1008 10.1038/bjp.2008.177 18469842 (Pubitemid 351915071)
57. Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats. RM Bitencourt, FA Pamplona, RN Takahashi, Eur Neuropsychopharmacol 2008 18 849 859 10.1016/j.euroneuro.2008.07.001 18706790
58. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. SH Kim, SJ Won, XO Mao, C Ledent, K Jin, DA Greenberg, J Pharmacol Exp Ther 2006 319 150 154 10.1124/jpet.106.107698 16831955 (Pubitemid 44455119)
59. Endocannabinoids modulate stress-induced suppression of hippocampal cell proliferation and activation of defensive behaviours. MN Hill, JS Kambo, JC Sun, BB Gorzalka, LA Galea, Eur J Neurosci 2006 24 1845 1849 10.1111/j.1460-9568. 2006.05061.x 17067290 (Pubitemid 44583468)
60. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. C Ledent, O Valverde, G Cossu, F Petitet, JF Aubert, F Beslot, GA Bohme, A Imperato, T Pedrazzini, BP Roques, et al. Science 1999 283 401 404 10.1126/science.283.5400.401 9888857 (Pubitemid 29045294)
61. Genetic influence on neurogenesis in the dentate gyrus of adult mice. G Kempermann, HG Kuhn, FH Gage, Proc Natl Acad Sci USA 1997 94 10409 10414 10.1073/pnas.94.19.10409 9294224 (Pubitemid 27407055)
62. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. CG Reich, ME Taylor, MM McCarthy, Behav Brain Res 2009 203 264 269 10.1016/j.bbr.2009.05.013 19460405
63. The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. T Vitalis, J Laine, A Simon, A Roland, C Leterrier, Z Lenkei, Eur J Neurosci 2008 28 1705 1718 10.1111/j.1460-9568.2008.06484.x 18973587
64. Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour. BK Keeney, DA Raichlen, TH Meek, RS Wijeratne, KM Middleton, GL Gerdeman, T Garland Jr, Behav Pharmacol 2008 19 812 820 10.1097/FBP.0b013e32831c3b6b 19020416
65. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. MN Hill, AK Titterness, AC Morrish, EJ Carrier, TT Lee, J Gil-Mohapel, BB Gorzalka, CJ Hillard, BR Christie, Hippocampus 2009 20 4 513 23
66. CB1 receptor deficiency decreases wheel-running activity: Consequences on emotional behaviours and hippocampal neurogenesis. S Dubreucq, M Koehl, DN Abrous, G Marsicano, F Chaouloff, Exp Neurol 2010 224 1 106 113 10.1016/j.expneurol.2010.01.017 20138171
67. Voluntary exercise and sucrose consumption enhance cannabinoid CB1 receptor sensitivity in the striatum. V De Chiara, F Errico, A Musella, S Rossi, G Mataluni, L Sacchetti, A Siracusano, M Castelli, F Cavasinni, G Bernardi, et al. Neuropsychopharmacology 35 374 387 10.1038/npp.2009.141 19776732
68. A functional role for adult hippocampal neurogenesis in spatial pattern separation. CD Clelland, M Choi, C Romberg, GD Clemenson, A Fragniere, P Tyers, S Jessberger, LM Saksida, RA Barker, FH Gage, TJ Bussey, Science 2009 325 210 213 10.1126/science.1173215 19590004
69. A functional hypothesis for adult hippocampal neurogenesis: avoidance of catastrophic interference in the dentate gyrus. L Wiskott, MJ Rasch, G Kempermann, Hippocampus 2006 16 329 343 10.1002/hipo.20167 16435309
70. Deletion of TrkB in adult progenitors alters newborn neuron integration into hippocampal circuits and increases anxiety-like behavior. M Bergami, R Rimondini, S Santi, R Blum, M Gotz, M Canossa, Proc Natl Acad Sci USA 2008 105 15570 15575 10.1073/pnas.0803702105 18832146
71. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. JM Revest, D Dupret, M Koehl, C Funk-Reiter, N Grosjean, PV Piazza, DN Abrous, Mol Psychiatry 2009 10 959 67 10.1038/mp.2009.15
72. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. A Zimmer, AM Zimmer, AG Hohmann, M Herkenham, TI Bonner, Proc Natl Acad Sci USA 1999 96 5780 5785 10.1073/pnas.96.10.5780 10318961 (Pubitemid 29234695)
73. Visualization of neurogenesis in the central nervous system using nestin promoter-GFP transgenic mice. M Yamaguchi, H Saito, M Suzuki, K Mori, Neuroreport 2000 11 1991 1996 10.1097/00001756-200006260-00037 10884058 (Pubitemid 30429150)
74. Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. H Van Praag, G Kempermann, FH Gage, Nat Neurosci 1999 2 266 270 10.1038/6368 10195220 (Pubitemid 30491298)
75. Place navigation impaired in rats with hippocampal lesions. RG Morris, P Garrud, JN Rawlins, J O'Keefe, Nature 1982 297 681 683 10.1038/297681a0 7088155 (Pubitemid 12096189)
76. Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: a study using mice with a modified beta-amyloid precursor protein gene. DP Wolfer, U Muller, M Stagliar, HP Lipp, Brain Res 1997 771 1 13 10.1016/S0006-8993(97)00673-2 9383002 (Pubitemid 27465684)